Kleo Pharmaceuticals Inc.

U. Of Texas Research Branch Maintains Hectic Partnering Pace The increasingly busy University of Texas MD Anderson Cancer Center inked three new alliances with biopharmaceutical companies in the pas

Myriad clinical trials are planned or are already under way around the world as pharma and biotech companies, universities and research organizations turn their focus to trying to find treatments for

For Scrip ’s annual preview of the year to come, our journalists contacted more than 80 industry executives and experts for their views on the outlook for 2020. In the first in a series looking at th

Kleo Pharmaceuticals Inc. thinks it can complement biological therapy in immuno-oncology and perhaps even supplant some of those therapeutics with a versatile, modular small molecule technology platf